Emelia J Benjamin, MD, ScM
Professor of Medicine and Epidemiology, Assistant Provost for Faculty Development at Boston University, and Investigator at the Framingham Heart Study. Author of over 500 peer-reviewed publications focusing on the genetics, epidemiology, and prognosis of cardiovascular conditions and markers including atrial fibrillation, echocardiographic findings, vascular function and systemic inflammation.
Susan Smyth, MD
Jeff Gill Professor of Cardiology, Chief of the Division of Cardiovascular Medicine, and the Director of the Gill Heart and Vascular Institute at the University of Kentucky. Dr. Smyth’s research focuses on the interplay between inflammation and thrombosis and the contribution of extracellular mediators and blood and vascular cell-surface signaling receptors in vascular disease. Her clinical interests are in arterial and venous thrombosis prevention, diagnosis, and management.
Sumeet Chugh, MD
SECRETARY / TREASURER
Pauline and Harold Price Professor of Cardiac Electrophysiology, Director of the Hearth Rhythm Center and Associate Director of the Heart Institute at Cedars-Sinai, Los Angeles, and Professor of Medicine-in-Residence at UCLA. His scientific career is dedicated to understanding sudden cardiac death: how often it occurs, the underlying causes, and the identification of novel risk factors. Using a real-time population cohort within two large communities of more than one million residents, the Sudden Unexpected Death Study has resulted in a biobank of phenotypes and biomarkers that are currently under investigation as tools of prediction and prevention.
Robert Simari, MD
1 year term
Professor of Medicine, Executive Vice Chancellor of the University of Kansas Medical Center and Executive Dean of the School of Medicine, his research interests include atherosclerosis, cardiovascular cell therapy, vascular biology, molecular medicine, angiogenesis, and thrombosis with the aim to better define the coordinated regulation of thrombosis and angiogenesis, define the phenotype and function of progenitor cells in the adult vasculature, develop novel biologic approaches to generation of prosthetic heart valves, and perform early (first-in-man or phase I) clinical trials of novel therapies for cardiovascular disease. Focus areas include vascular hematopoietic progenitor cells, biologic heart valves, cardiovascular cell therapy research network, and B-type natriuretic peptide (BNP).
Michelle Albert, MD
2nd year of 3 year term
Dr. Michelle A. Albert is a Professor in Medicine and Cardiologist at the University of California at San Francisco (UCSF) and founding director of the CeNter for the StUdy of AdveRsiTy and CardiovascUlaR DiseasE (NURTURE Center). The UCSF NURTURE Center is an interdisciplinary translational research center seeks to perform exploratory and interventional scientific research to understand the “biology of adversity” and its impact on health, particularly cardiovascular health. Research in the NURTURE Center seeks to decipher and develop novel initiatives aimed at improving patient behavior and adherence taking into account the interplay between social determinants of health and biological processes to attain advantaged health and well-being of persons at risk across the life-course.
Charles Lowenstein, MD
2nd year of 3 year term
Charles J. Lowenstein, M.D. is Professor of Medicine, Chief of Cardiology, and Director of the Cardiovascular Research Institute at the University of Rochester School of Medicine and Dentistry. His research is focused on vascular biology. One team of researchers explores mechanisms of exocytosis, through which endothelial cells release pro-inflammatory and pro-thrombotic mediators. A second group of scientists study how platelets communicate with endothelial cells. A third area of research involves an exploration of the role of microRNA in endothelial cells. A fourth team investigates how nitric oxide affects vascular inflammation.
Barry London, MD, PhD
1st year of 3 year term
Dr. London is Chief of the Division of Cardiovascular Medicine and Director of the Abboud Cardiovascular Research Center at the University of Iowa. His laboratory studies the molecular and genetic basis of arrhythmias and sudden cardiac death using animal models, families with inherited arrhythmia syndromes, and patient cohorts with heart failure. He has held near continuous funding from the NIH through his career, including a Pioneer Award. He is a member of the American Society for Clinical Investigation, the Association of American Physicians, the Association of University Cardiologists, and the American Clinical and Climatological Association. He has served as Editor-in-Chief of the Journal of the American Heart Association since 2014.